Shanghai Haohai Biological Technology Co. Ltd (5HB) — Capital Reinvestment Ratio
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Capital Reinvestment Ratio of 0.37x as of June 2023, meaning it reinvests 0% of its operating cash flow (€141.99 Million) in capital expenditures (€53.01 Million). See cash generation quality of Shanghai Haohai Biological Technology Co to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Haohai Biological Technology Co. Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Shanghai Haohai Biological Technology Co. Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2024. For live market cap and broader valuation context, see Shanghai Haohai Biological Technology Co market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.56x | €648.57 Million | €365.49 Million | ▲ +4.2% |
| 2023 | 0.54x | €634.45 Million | €343.10 Million | ▼ -59.5% |
| 2022 | 1.34x | €231.30 Million | €309.21 Million | ▲ +68.9% |
| 2021 | 0.79x | €342.29 Million | €270.88 Million | ▲ +9.3% |
| 2020 | 0.72x | €262.07 Million | €189.70 Million | ▲ +1.4% |
| 2019 | 0.71x | €348.91 Million | €249.18 Million | ▲ +84.8% |
| 2018 | 0.39x | €391.28 Million | €151.21 Million | ▼ -1.3% |
| 2017 | 0.39x | €343.06 Million | €134.29 Million | ▲ +31.7% |
| 2016 | 0.30x | €254.49 Million | €75.67 Million | — |